Blade Air Mobility, Inc. provides air transportation and logistics for hospitals across the United States. The Company transports human organs for transplant, and for passengers, with helicopter and fixed wing services primarily in the Northeast United States, Southern Europe and Western Canada. The Company's segments include Passenger and Medical. Its Passenger segment includes Short Distance and Jet and Other. Short Distance business consists primarily of helicopter and amphibious seaplane flights in the United States, Canada and Europe. Jet and Other business consist principally of non-medical jet charter and by-the-seat jet flights between New York and South Florida. Its Medical segment includes MediMobility Organ Transport, which consists primarily of transportation of human organs for transplant and/or the medical teams supporting these services. It also offers additional services including donor logistics coordination and support for evaluating potential donor organs.
äŒæ¥ã³ãŒãBLDE
äŒç€ŸåBlade Air Mobility Inc
äžå Žæ¥Sep 17, 2019
æé«çµå¶è²¬ä»»è
ãCEOãMr. Scott M. Wunsch
åŸæ¥å¡æ°310
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Sep 17
æ¬ç€Ÿæåšå°31 Hudson Yards
éœåžNEW YORK
蚌åžååŒæNASDAQ Capital Market Consolidated
åœUnited States of America
éµäŸ¿çªå·10001
é»è©±çªå·12129671009
ãŠã§ããµã€ãhttps://ir.blade.com/
äŒæ¥ã³ãŒãBLDE
äžå Žæ¥Sep 17, 2019
æé«çµå¶è²¬ä»»è
ãCEOãMr. Scott M. Wunsch
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã